Search - Industry Global News24

United States Equine Serum for Therapy Market 2015 – 2029

The United States equine serum for therapy market was valued at US$ 14,818 Thousands in 2020 and is projected to grow at a CAGR of 3.2% over the forecast period. Increasing demand for protection of livestock using equine serum-based vaccines is expected to drive the growth of the United States eq...

Novavax and Serum Institutes COVID-19 vaccine receives EUA in Indonesia

Novavax Inc, a Biotechnology firm and Serum Institute of India announced that they have received the first emergency use authorization for the COVID-19 vaccine in Indonesia.

Highlights

• Novavax’s Covi...

Mumbai based lab develops world’s first rapid test kit for Silicosis

Scientists from Mumbai have developed a rapid test for testing silicosis in people. Silicosis is progressive lung disease caused by exposure to silica. The kit helps in detecting the levels of serum CC16 in blood.

Highlights

Scientists develop a rapid ...

Adar Poonawalla helps Indian Students studying abroad

The CEO of Serum group of Institutes, Adar Poonawalla has said on Thursday that he has set aside 10 crore rupees for students studying abroad. Covishield, made by Serum group of Institutes, is not yet accepted by many nations.

On Thursday, he said that not many nations have approved Cov...

Global Equine Serum Market by Current Industry Status, Growth Opportunities

Eequine serum, also known as horse serum, is defined as a nutrient-rich fluid that is derived from the blood of controlled donor horse herds. However, this serum does not contain red blood cells or any other clotting components that the blood of horse (or any living creature) contains. Equine ser...

US SAYS IT REMEMBERS INDIA’S GENEROSITY IN EARLY DAYS OF COVID-19 PANDEMIC

Highlights

• The United States on Tuesday said it will be delivering raw materials to the Serum Institute of India (SII) for the manufacturing of the Oxford-AstraZeneca Covishield vaccine

• After denying initially, the US has agreed to help India in every way possibl...

US, EUROPE BAN EXPORT OF CRITICAL RAW MATERIALS REQUIRED TO MAKE COVID VACCINES: SII CEO POONAWALLA

Highlights

• The United States along with the European nations have imposed a ban on export of critical raw materials needed to manufacture the vaccine for dreadful coronavirus

• The Serum Institute CEO said that he understands the increasing demand for retaining all...

TREAT YOUR SKIN WITH HYALURONIC ACID

Highlights –

Treat your skin with Hyaluronic acid.
Hyaluronic acid helps to keep keep your tissues well lubricated and moist.
It could be used as topical serums, eye drops, and injections.
Hyaluronic acid can help your ski...

COVISHIELD VACCINE MAYBE RECOMMENDED FOR INTERNATIONAL USE

HIGHLIGHTS

AstraZeneca is in talks with governments of many countries.
AstraZeneca is also engaging with multilateral organizations and many other partners around the world.
AstraZeneca wants broad and equitable access to the vaccine for ev...

SII RELEASES FAQ FACTSHEET FOR COVISHIELD VACCINE

HIGHLIGHTS

SII has released FAQ Factsheet for Covishield Vaccine.
The new factsheet details information for vaccine recipients regarding the benefits and common side-effects of the Covishield vaccine.
The Covishield has been approved for re...

COVID-19 VACCINE: NOVAVAX TO DELIVER 100 MILLION DOSES TO THE U.S. BY JANUARY 2021

Highlights

• Novavax in the month of August had inked a deal with Serum Institute of India, the largest producer of vaccines in the world in order to produce a minimum of its COVID-19 vaccine candidate

• The U.S. drug developer had previously said that it will supply...

SERUM INSTITUTE CEO WARNS OF COVID-19 VACCINE SHORTAGE TILL 2024

HIGHLIGHTS

Serum Institute CEO says that till 2024, coronavirus vaccine availability will not be enough.
Two doses of vaccine are required to create immunity against coronavirus.

On Monday, 14 SEP 2020, Adar Poonawalla, the CEO of Se...

COVID-19 VACCINE: SERUM INSTITUTE OF INDIA TO BEGIN PHASE 2 TRIALS OF OXFORD VACCINE THIS WEEK

Highlights

• The Serum Institute of India has stated that it has shortlisted 10 centres across the nation to conduct Phase II and Phase III human clinical trials of COVID-19 vaccine developed by the University of Oxford

• On Monday, the national expert group on vacci...

INDIA’S COVID-19 TALLY AT 27,02,742, DEATH TOLL GOES UP TO 51,797

• Current Total Cases: 2,702,742

• Total Deaths : 51,797

• Cumulative recoveries : 1,977,779

• Active cases: 673,166

• Top five states that has the maximum number of cases :

Maharashtra: Cases 604,358, number of deat...

NOVAVAX, SERUM INSTITUTE OF INDIA JOIN HANDS TO SUPPLY COVID-19 VACCINE

Highlights

• The Serum Institute of India will have exclusive rights for the COVID-19 vaccine in India and non-exclusive rights during the pandemic period in all countries except those designated as upper-middle or high-income nations

• The COVID-19 vaccine developed...